EDGAR Filing Documents for 0001171843-14-001921

Form 8-K - Current report:

SEC Accession No. 0001171843-14-001921

Filing Date

2014-04-29

Accepted

2014-04-28 19:20:40

Documents

Period of Report

2014-04-28

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K FILING DOCUMENT	document.htm	8-K	7208
2	PRESS RELEASE	newsrelease.htm	EX-99	8925
	Complete submission text file	0001171843-14-001921.txt		17281

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 14790866
SIC: 2834 Pharmaceutical Preparations